<DOC>
	<DOC>NCT00690404</DOC>
	<brief_summary>A open label two way crossover formulation and food effect study in healthy volunteers to assess the pharmacokinetics of a single dose of AZD2066 new oral solid formulation and an oral solution</brief_summary>
	<brief_title>AZD 2066 Single Dose Formulation and Food Effect Study in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Clinical normal physical findings, including BP, pulse rate &gt;45 bpm, ECG and laboratory assessments Body Mass Index (BMI) of ≥18 to ≤30 kg/m2 and weight of ≥50 to ≤100 kg History of hypersensitivity, allergy or atopic/skin disease as judged by Investigator. History of somatic or psychiatric disease/condition, which may interfere with the objectives of the study as judged by the Investigator.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>formulation</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>crossover formulation</keyword>
	<keyword>food effect</keyword>
	<keyword>oral solution</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>